Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapyS Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Entecavir treatment of chronic hepatitis DGökhan Kabaçam, F Oguz Onder, Mustafa Yakut, et al.
BMC Infectious Diseases|December 14, 2011
Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic reviewMehlika Toy, Fatih Oguz Önder, Tanja Wörmann, et al.
Viruses|December 28, 2021
A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus InfectionFlorian A Lempp, Imme Roggenbach, Shirin Nkongolo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 21, 2012
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income countryMehlika Toy, Fatih Oguz Onder, Ramazan Idilman, et al.
Archives of Virology|October 11, 2011
Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patientsInci Celik, Ersin Karatayli, Emrah Cevik, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2012
Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MSSenem Ceren Karatayli, S Gökçe Alagöz, Dilşa Mizrak, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Fatigue of cholestasis and the serotoninergic neurotransmitter system in the ratTurgay Celik, M Zafer Gören, Kubilay Cinar, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 22, 2005
Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosisHasibe Verdi, Elif Sare Koytak, Oğuz Onder, et al.
Antiviral Therapy|February 28, 2017
Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-upFatih Karakaya, Sevil Özer, Çağdaş Kalkan, et al.
Pageof 12